(Q48423257)

English

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

fluticasone propionate

1 reference

based on heuristic

inferred from title

author name string

Peden DB

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

Berger WE

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

Noonan MJ

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

Thomas MR

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

Hendricks VL

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

Hamedani AG

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

Mahajan P

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

House KW

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

The Journal of Allergy and Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

102

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

32-38

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

The pathology of asthma, with special reference to changes in the bronchial mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Early childhood respiratory symptoms and the subsequent diagnosis of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent cough in childhood and its relation to asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma and wheezing in the first six years of life. The Group Health Medical Associates

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The human pharmacology of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo controlled trial of fluticasone propionate in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate in children with moderate asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970052-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0091-6749(98)70052-1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9679845

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48423257&oldid=2082359138"